• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 4. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 5. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Recent Advances in Chemical and Biomedical Research: Insights on 51209-49-5 and Cyclohexanone-d10

In the rapidly evolving field of chemical and biomedical research, the exploration of novel compounds and their applications continues to drive innovation. Among these, the compound with the CAS number 51209-49-5 and the deuterated solvent Cyclohexanone-d10 have garnered significant attention due to their unique properties and potential applications in pharmaceuticals, diagnostics, and material science. This research briefing aims to provide a comprehensive overview of the latest findings related to these substances, highlighting their roles in contemporary research and development.

The compound 51209-49-5, a relatively understudied molecule, has recently emerged as a candidate for various therapeutic applications. Recent studies have focused on its structural characteristics and interactions with biological targets, suggesting potential utility in drug design. Meanwhile, Cyclohexanone-d10, a deuterated analog of cyclohexanone, has been widely utilized as a solvent in nuclear magnetic resonance (NMR) spectroscopy due to its ability to provide sharp and well-resolved spectra. Its applications extend to pharmacokinetic studies and metabolic research, where deuterium labeling plays a crucial role in tracking molecular pathways.

One of the key advancements in the study of 51209-49-5 involves its potential as an inhibitor of specific enzymatic pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits selective binding to certain kinases, making it a promising candidate for targeted cancer therapies. The research employed advanced computational modeling and in vitro assays to validate these findings, paving the way for further preclinical investigations.

In parallel, Cyclohexanone-d10 has been instrumental in advancing metabolic research. A recent study in Analytical Chemistry highlighted its use in stable isotope labeling to monitor drug metabolism in vivo. The study reported enhanced sensitivity and accuracy in detecting metabolic intermediates, underscoring the solvent's value in pharmacokinetic profiling. Additionally, Cyclohexanone-d10 has found applications in polymer chemistry, where its deuterated properties facilitate the study of polymer dynamics and interactions.

Despite these promising developments, challenges remain in the widespread adoption of these compounds. For 51209-49-5, issues such as synthetic scalability and bioavailability need to be addressed to transition from laboratory research to clinical applications. Similarly, the high cost and limited availability of Cyclohexanone-d10 pose barriers to its broader use in research settings. However, ongoing efforts to optimize synthesis protocols and reduce production costs are expected to mitigate these challenges in the near future.

In conclusion, the latest research on 51209-49-5 and Cyclohexanone-d10 underscores their potential to contribute significantly to chemical and biomedical advancements. While further studies are needed to fully exploit their capabilities, the current findings provide a solid foundation for future exploration. Researchers and industry professionals are encouraged to consider these compounds in their work, leveraging their unique properties to drive innovation in drug development, diagnostics, and material science.

• 502-49-8(Cyclooctanone)
• 5441-51-0(4-ethylcyclohexan-1-one)
• 4894-75-1(4-phenylcyclohexan-1-one)
• 3041-16-5(1,4-Dioxan-2-one)
• 112-12-9(2-Undecanone)
• 100-64-1(N-cyclohexylidenehydroxylamine)
• 693-54-9(Decan-2-one)
• 110-13-4(hexane-2,5-dione)
• 637-88-7(1,4-Cyclohexanedione)
• 98-53-3(4-tert-butylcyclohexan-1-one)